Printer Friendly

FOREST LABORATORIES FILES REGISTRATION STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION

 FOREST LABORATORIES FILES REGISTRATION STATEMENT
 WITH THE SECURITIES AND EXCHANGE COMMISSION
 NEW YORK, Jan. 31 /PRNewswire/ -- Forest Laboratories, Inc. (AMEX: FRX), an international pharmaceutical manufacturer and marketer, announced today that it had filed a registration statement with the Securities and Exchange Commission covering 3,000,000 shares, 1,515,000 of which are to be sold by the company and 1,485,000 shares by selling shareholders.
 The company said that the proceeds of the company's offering would be used for working capital and general corporate purposes.
 The shares are to be offered through underwriters led by Lehman Brothers, Donaldson, Lufkin & Jenrette Securities Corporation and Morgan Stanley & Co. Incorporated.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 A copy of the offering prospectus may be obtained from the Prospectus Department of Lehman Brothers, 250 West St., New York, NY 10013.
 -0- 1/31/92
 /CONTACT: Kenneth E. Goodman vice president-finance of Forest Laboratories, 212-421-7850/
 (FRX) CO: Forest Laboratories, Inc. ST: New York IN: MTC SU: OFR


GK-SH -- NY013 -- 5507 01/31/92 09:37 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 31, 1992
Words:264
Previous Article:FIRST ROUND IN LEGAL AND MORAL BATTLE WITH RAYTHEON'S AMANA HAS BEEN WON BY ITS LARGEST DISTRIBUTOR
Next Article:LECTEC MAINTAINS SERIES OF PROFITABLE QUARTERS
Topics:


Related Articles
ROYCE LABORATORIES FILES FOR $6 MILLION SECONDARY PUBLIC OFFERING
INTRAMED LABORATORIES INC. FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF COMMON STOCK
ABBOTT FILES SHELF REGISTRATION WITH SEC
SMITHKLINE BEECHAM FILES SHELF REGISTRATION
Abbott Files Shelf Registration with SEC
Abbott Files Shelf Registration With SEC.
Roche to Sell Up to 6.0 Million Shares of LabCorp.
Kos Pharmaceuticals, Inc. Files Universal Shelf Registration Statement.
Adams Laboratories Announces Initial Public Offering.
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R).

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters